PROMEDITECH: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PROMEDITECH
Largest movements
- Receivables within one year -€4,422
down €4,422 (-75.7%), from €5,842 to €1,420
of which Trade receivables: -€4,500
- Cash +€4,207
up €4,207 (+7.3%), from €57,618 to €61,824
mainly Receivables within one year (+€4,422) and Accrued charges and deferred income (+€1,738)
No liability line moved by more than 1% of the balance sheet total.
- Gross operating margin +€528
up €528 (+26.7%), from -€1,977 to -€1,449
- Financial income +€28
up €28 (+12.4%), from €225 to €253
- Financial charges +€23
up €23 (+11.7%), from €199 to €222
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €190,682 | €191,967 | +€1,285 | +0.7% |
| Fixed assets | 21/28 | €127,159 | €127,159 | = | 0.0% |
| Financial fixed assets | 28 | €127,159 | €127,159 | = | 0.0% |
| Current assets | 29/58 | €63,523 | €64,808 | +€1,285 | +2.0% |
| Amounts receivable within one year | 40/41 | €5,842 | €1,420 | -€4,422 | -75.7% |
| Trade receivables | 40 | €4,500 | €0 | -€4,500 | -100.0% |
| Other amounts receivable | 41 | €1,342 | €1,420 | +€78 | +5.8% |
| Cash at bank and in hand | 54/58 | €57,618 | €61,824 | +€4,207 | +7.3% |
| Deferred charges and accrued income | 490/1 | €63 | €1,564 | +€1,500 | +2364.8% |
| Total equity and liabilities | 10/49 | €190,682 | €191,967 | +€1,285 | +0.7% |
| Equity | 10/15 | €83,044 | €81,239 | -€1,805 | -2.2% |
| Contributions | 10/11 | €53,600 | €53,600 | = | 0.0% |
| Reserves | 13 | €5,360 | €5,360 | = | 0.0% |
| Non-distributable reserves | 130/1 | €5,360 | €5,360 | = | 0.0% |
| Reserves not available under the articles | 1311 | €5,360 | €5,360 | = | 0.0% |
| Profit (loss) carried forward | 14 | €24,084 | €22,279 | -€1,805 | -7.5% |
| Amounts payable | 17/49 | €107,638 | €110,728 | +€3,091 | +2.9% |
| Amounts payable within one year | 42/48 | €107,638 | €108,990 | +€1,353 | +1.3% |
| Trade debts | 44 | €1,707 | €3,031 | +€1,324 | +77.5% |
| Suppliers | 440/4 | €1,707 | €3,031 | +€1,324 | +77.5% |
| Other amounts payable | 47/48 | €105,931 | €105,960 | +€29 | 0.0% |
| Accrued charges and deferred income | 492/3 | - | €1,738 | +€1,738 | |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | -€1,977 | -€1,449 | +€528 | +26.7% |
| Operating profit (loss) | 9901 | -€2,361 | -€1,836 | +€525 | +22.2% |
| Financial income | 75/76B | €225 | €253 | +€28 | +12.4% |
| Recurring financial income | 75 | €225 | €253 | +€28 | +12.4% |
| Financial charges | 65/66B | €199 | €222 | +€23 | +11.7% |
| Recurring financial charges | 65 | €199 | €222 | +€23 | +11.7% |
| Profit (loss) for the period before taxes | 9903 | -€2,335 | -€1,805 | +€529 | +22.7% |
| Income taxes | 67/77 | €0 | €0 | = | |
| Profit (loss) for the period | 9904 | -€2,335 | -€1,805 | +€529 | +22.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,335 | -€1,805 | +€529 | +22.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.